GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CNBX Pharmaceuticals CNBX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

CNBX Pharmaceuticals — daily CNBX Delayed
Market value
$9,065
Last close × shares
Volume
3
Shares, 9 Nov 2026

About CNBX Pharmaceuticals

From its filings with the US Securities and Exchange Commission

SEC filings

CNBX Pharmaceuticals is based in Bethesda, Maryland and is incorporated in Nevada. Its shares trade on OTC under the ticker CNBX. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 August 2025, it reported revenue of $0 and a net loss of $313,976. At that date it held total assets of $18,437 and shareholders' equity of −$2.5m.

In its own words

Corporation, purchased 20,500,000 shares of restricted stock of the Company, thus acquiring control of the Company.

Inc. incorporated a wholly owned subsidiary in Israel, named “G.R.I.N Ultra Ltd”, dedicated to advanced research and development.

Sourasky Medical Center in Tel-Aviv, Israel, where he is head of the Endoscopic Submucosal Dissection (ESD) program.

On May 12, 2022, the Company effected a reverse-split of its common stock on a 1:120 basis.

We believe, therefore, that cannabinoid combinations may hold promise for an improved anti-proliferative strategy for cancer management.

1,392,445people living with CRC in 2021(Source: National Cancer Institute. “Cancer Stat Facts: Colorectal Cancer”).

According to the American Cancer Society, an estimated one-third to one-half of all individuals will eventually develop one or more adenomas.

Quoted from its 10-K, filed 1 Dec 2025. Read the filing on SEC.gov ↗

More about CNBX Pharmaceuticals →

Latest on CNBX Pharmaceuticals

Our reporting

We have not reported on CNBX Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is CNBX Pharmaceuticals's ticker?

CNBX Pharmaceuticals trades as CNBX on its US listing, under ISIN US13764M2098.

What was CNBX Pharmaceuticals's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.